NSW Public drug warning- High dose MDMA tablets - pink irregular shape with Audi logo
Published on August 3, 2022
Emergency: If you are experiencing an emergency, please call an ambulance on 000, or if you need to speak to someone urgently please call the National Alcohol and Other Drug Hotline on 1800 250 015.
High dose MDMA tablets have been found in NSW, average dose 196mg
Know the risks
- You are at increased risk of harm if you:
- take multiple MDMA (ecstasy) tablets or capsules
- take a higher-dose MDMA (ecstasy) tablet or capsule
- use other stimulant drugs (e.g. methamphetamine, cocaine or caffeine) at the same time
- use alcohol, certain medicines, or illicit drugs at the same time
- MDMA (ecstasy) is often poorly manufactured and the amount of MDMA in a tablet or capsule can vary a lot, even within the same batch. The dose of MDMA tablets recently circulating in NSW varied by up to six-fold.
- The time from taking the drug to feeling any effect can vary significantly depending on the drug as well as the individual person.
- MDMA (ecstasy) has been linked to death, serious harm and life-long complications.
Effects to look out for
- Feeling really hot and sweaty, light headedness, rigid muscles (e.g. difficulty walking), confusion or agitation, racing pulse/heart, feeling aggressive, uncontrolled repetitive movements, vomiting, seizures, difficult to rouse / unconscious
Getting help
- Seek help immediately from your nearest emergency department or call Triple Zero (000).
- Start CPR if someone is not breathing.
Support and advice
For free and confidential advice:
- Call Alcohol and Drug Information Service (ADIS) on 1800 250 015 at any time 24/7. Start a Web Chat with an ADIS counsellor Mon-Fri, 8.30am-5pm.
- Call NUAA on 1800 644 413 (Mon-Fri 9am-5pm) to speak to a peer or visit NUAA for a range of resources.
- Call the NSW Poisons Information Centre on 13 11 26 for information on adverse effects from drugs.
- Visit Your Room for fact sheets and other resources.
Current as at: Friday 10 June 2022
Contact page owner: Centre for Alcohol and Other Drugs